Research Paper Volume 13, Issue 5 pp 7481—7498

Identification and validation of a glycolysis-associated multiomics prognostic model for hepatocellular carcinoma

GMPM predicts OS in HCC patients. The distribution of survival status and risk scores in TCGA (A) and ICGC (D), respectively. The expression difference between high- and low-risk groups in TCGA (B) and ICGC (E). Kaplan-Meier survival curves to verify the predictive effect of GMPM in TCGA (C) and ICGC (F). GMPM, glycolysis-associated multi-omics prognostic model; OS, overall survival.

Figure 6. GMPM predicts OS in HCC patients. The distribution of survival status and risk scores in TCGA (A) and ICGC (D), respectively. The expression difference between high- and low-risk groups in TCGA (B) and ICGC (E). Kaplan-Meier survival curves to verify the predictive effect of GMPM in TCGA (C) and ICGC (F). GMPM, glycolysis-associated multi-omics prognostic model; OS, overall survival.